PhD student: Chemistry, Pharmaceutical, Medical Technology
PhD student in the field of Chemistry / Pharmaceutical / Medical Technology at the Clay Sorption Mechanism Group of the Waste Management Laboratory, Paul Scherrer Institute Switzerland (PSI)- Mittelland (SO, AG).
PSI is the largest research institute for natural and engineering sciences in Switzerland. We perform cutting-edge research in the fields of matter and materials, energy and environment and human health.
Tasks Involved
Selected candidate will investigate the interaction between redox-sensitive radionuclides (eg, U, Tc, or Se), and purified Fe (II) / (III) -containing clay minerals by combining different approaches:
- adsorption experiments with radionuclides under different relevant geochemical conditions,
- molecular scale speciation using X-ray absorption spectroscopy and
- adsorption modeling.
The aim is to correlate mineral properties with respect to its redox reactive iron content to the degree of radionuclide retention and molecular scale surface speciation. X-Ray absorption spectroscopic measurements at the Rossendorf Beamline (ROBL) located at the European Synchrotron Radiation Facility (ESRF) in Grenoble (France) and at the Radiochemical A-type laboratory to evaluate and model your data.
Requirements
- Highly motivated individual with good communication skills in English and easily adaptable to different working environments.
- Master degree / Diploma in chemistry, earth or environmental sciences or related field.
- X-ray absorption spectroscopy. In electrochemistry or in synchrotron-based X-ray absorption spectroscopy.
Application Procedure
Please submit your application online by 31 July 2019 (including addresses of referees) for the position as a PhD student (index no. 4402-00).
Quick Overview————- | |
Organization | Paul Scherrer Institut (PSI) |
Fellowship Level | PhD |
Country | Switzerland |
Subject areas | Chemistry / Pharmaceutical / Medical Technology |
Fellowship amount | varies |
Eligibility | Open to all nationalities |
Deadline | 31 July 2019 |
——————————————– |